New data highlight the contribution of IL-6 to vascular calcification in chronic inflammation. Given that increased vascular calcification and accelerated atherosclerosis occur in patients with chronic inflammatory diseases, new therapies that block the IL-6 pathway might reduce the risk of cardiovascular events in these patients.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Vascular calcification: from the perspective of crosstalk
Molecular Biomedicine Open Access 18 October 2023
-
Early inflammation precedes cardiac fibrosis and heart failure in desmoglein 2 murine model of arrhythmogenic cardiomyopathy
Cell and Tissue Research Open Access 08 July 2021
-
Calciphylaxis in end-stage kidney disease: outcome data from the United Kingdom Calciphylaxis Study
Journal of Nephrology Open Access 06 February 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
López-Mejías, R. et al. Cardiovascular risk assessment in patients with rheumatoid arthritis: the relevance of clinical, genetic and serological markers. Autoimmun. Rev. 15, 1013–1030 (2016).
Vattikuti, R. & Towler, D. A. Osteogenic regulation of vascular calcification: an early perspective. Am. J. Physiol. Endocrinol. Metab. 286, E686–E696 (2004).
Shao, J. S., Cai, J. & Towler, D. A. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler. Thromb. Vasc. Biol. 26, 1423–1430 (2006).
Massy, Z. A. & Hénaut, L. New insights into the key role of interleukin 6 in vascular calcification of chronic kidney disease. Nephrol. Dial. Transplant. 33, 543–548 (2018).
Kurozumi, A. et al. IL-6 and sIL-6R induces STAT3-dependent differentiation of human VSMCs into osteoblast-like cells through JMJD2B-mediated histone demethylation of RUNX2. Bone 124, 53–61 (2019).
Castañeda, S., Nurmohamed, M. T. & González-Gay, M. A. Cardiovascular disease in inflammatory rheumatic diseases. Best. Pract. Res. Clin. Rheumatol. 30, 851–869 (2016).
Corrales, A. et al. Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. Ann. Rheum. Dis. 72, 1764–1770 (2013).
Rho, Y. H. et al. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 61, 1580–1585 (2009).
Fukuyo, S. et al. IL-6-accelerated calcification by induction of ROR2 in human adipose tissue-derived mesenchymal stem cells is STAT3 dependent. Rheumatology 53, 1282–1290 (2014).
López-Mejías, R. et al. Identification of a 3'-untranslated genetic variant of RARB associated with carotid intima-media thickness in rheumatoid arthritis: a genome-wide association study. Arthritis Rheumatol. 71, 351–360 (2019).
Acknowledgements
The work of M.A.G.-G is supported by grants from Fondo de Investigación Sanitaria (PI06/0024, PS09/00748, PI12/00060, PI15/00525 and PI18/00043) and RETICS Programs (RD12/0009 and RD16/0012) (RIER) from the Instituto de Salud Carlos III (ISCIII, Health Ministry, Spain) and European Union FEDER funds. R.L.-M. is a recipient of the Miguel Servet type I Program fellowship supported by ISCIII, co-funded by the European Social Fund (“Investing in your future”) (CP16/00033).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
M.A.G.-G declares that he has received research support from AbbVie, MSD, Jansen and Roche, and has received consultation fees or has participated in a company-sponsored speaker´s bureau from AbbVie, Pfizer, Roche, Sanofi, Celgene, Sobi and MSD. R.L.-M. declares no competing interests.
Rights and permissions
About this article
Cite this article
López-Mejías, R., González-Gay, M.A. IL-6: linking chronic inflammation and vascular calcification. Nat Rev Rheumatol 15, 457–459 (2019). https://doi.org/10.1038/s41584-019-0259-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-019-0259-x
This article is cited by
-
Vascular calcification: from the perspective of crosstalk
Molecular Biomedicine (2023)
-
Cartilage calcification in osteoarthritis: mechanisms and clinical relevance
Nature Reviews Rheumatology (2023)
-
Engineered Extracellular Vesicle-Based Therapies for Valvular Heart Disease
Cellular and Molecular Bioengineering (2023)
-
The innate immune system in human kidney inflammaging
Journal of Nephrology (2022)
-
Calciphylaxis in end-stage kidney disease: outcome data from the United Kingdom Calciphylaxis Study
Journal of Nephrology (2021)